Abstract:Background: the role of the R202Q (c.605G>A, p.Arg202Gln) missense variant of the MEFV gene has been debated as either a benign polymorphism or a potentially pathogenic mutation. We report and discuss here the case of a young female with corticosteroid-dependent recurrent pericarditis carrying the homozygous R202Q variant, exhibiting distinctive clinical features possibly influenced by this genetic variant. Methods: a 30-year-old woman with a previous diagnosis of cancer and recent respiratory infection presented with severe pleuritic chest pain, hypotension, tachycardia, and fever. Initial diagnostic evaluation indicated cardiac tamponade, and emergent pericardiocentesis was performed. Despite initial treatment with NSAIDs, colchicine, and corticosteroids, the patient experienced multiple recurrences. Genetic testing identified homozygous R202Q variant in the MEFV gene. Given the corticosteroid dependency and recurrent nature of her condition, IL-1 inhibitor anakinra was introduced, leading to significant improvement, although tapering below 150 mg per week failed to prevent recurrences. Results: the introduction of anakinra resulted in rapid symptom relief and resolution of pericardial effusion. However, attempts to taper or discontinue anakinra led to pericarditis recurrences. Ultimately, a maintenance dose of 50 mg every three days was established, which maintained remission for 18 months without recurrence. Despite multiple tapering attempts, further reduction in anakinra dosage was unsuccessful without triggering relapses. Conclusions: the R202Q variant, although typically considered benign, may contribute to an autoinflammatory phenotype resembling familial Mediterranean fever. This case underscores the potential pathogenicity of the homozygous R202Q variant in recurrent pericarditis and its responsiveness to IL-1 inhibition. In patients with corticosteroid-dependent recurrent pericarditis, genetic testing for the R202Q variant should be considered when anti-IL-1 drugs cannot be withdrawn. Further studies are warranted to elucidate the variant's role in pericardial inflammation and guide personalized treatment strategies.

Heterozygous Pyrin (MEFV) E148Q allele carriers indicate a reduced glaucoma risk for Turkish population: a prospective clinical analysis

E148Q variant: a familial Mediterranean fever-causing mutation or a sequence variant?

Clinical Associations of E148Q Heterozygosity: What to Expect From E148Q?

MEFV-Gene Analysis in Armenian Patients with Familial Mediterranean Fever: Diagnostic Value and Unfavorable Renal Prognosis of the M694V Homozygous Genotype—Genetic and Therapeutic Implications

A Dominant Pathogenic MEFV Mutation Causes Atypical Pyrin-Associated Periodic Syndromes

Mutations in the MEFV Gene in a Large Series of Patients with a Clinical Diagnosis of Familial Mediterranean Fever.

Molecular investigation of MEFV gene polymorphisms among patients with familial mediterranean fever-like symptoms

Non-Founder Mutations In The Mefv Gene Establish This Gene As The Cause Of Familial Mediterranean Fever (Fmf)

The significance of carrying MEFV variants in symptomatic and asymptomatic individuals

Association Between Mefv Mutations M694v And M680i And Behcet'S Disease: A Meta-Analysis

MEFV Mutations and Phenotype-Genotype Correlations in North African Jews and Armenians with Familial Mediterranean Fever.

The Role of the R202Q Variant of the MEFV Gene

Association of MEFV mutations and vascular involvement in Behçet's disease: a study from Hatay, Turkey

Influence of clusterin genetic variants on IOP elevation in pseudoexfoliation syndrome and pseudoexfoliative glaucoma in Turkish population

Pyrin dephosphorylation is sufficient to trigger inflammasome activation in familial Mediterranean fever patients

MEFV Gene Variant Alleles in Normal Population of Northwest of Iran, Ardabil Province

Unraveling the genome: Familial Mediterranean fever

Identification of Disease-Promoting HLA Class I and Protective Class II Modifiers in Japanese Patients with Familial Mediterranean Fever

High frequency of MEFV disease-causing variants in children with very-early-onset inflammatory bowel disease

Role of Mutual Information Profile Shifts in Assessing the Pathogenicity of Mutations on Protein Functions: The Case of Pyrin Variants Associated with Familial Mediterranean Fever

Heterozygous MEFV Mutation Leading to Renal Failure: A Case Study